Formulation and Characterization of Etoricoxib Suppositories for the Management of Hemorrhoids

依托考昔栓剂在痔疮治疗中的制备与特性研究

阅读:1

Abstract

OBJECTIVES: This study aimed to formulate and evaluate etoricoxib suppositories to improve patient compliance and drug efficacy in the management of hemorrhoids. MATERIALS AND METHODS: Suppositories were prepared using glycerin and gelatin. The prepared suppositories were evaluated for content uniformity, homogenization, hardness, weight variation, disintegration time, texture analysis, and in vitro drug release. RESULTS: Hardness, weight variation, disintegration time, and content uniformity values were found in the range of 4.00±0.50 to 7.50±0.50 kg/cm(3), 1.20±0.03 to 1.31±0.01 g, 11.00 to 19.05 min, and 66.98±0.86 to 80.76±3.60%, respectively. The SB3 gave 91.47±17.74% drug release in 6 h, whereas the SB1 gave 99.08±3.40% drug release in 12 h. Drug release from all formulations of suppositories was supported by zero-order, first-order, and Higuchi plots, except for SB4. The mechanism of drug release from all suppositories was fickian diffusion-based. The SB2 results were found to be more appropriate than those of the other batches. CONCLUSION: These results confirm that the prepared formulation has a future scope and should be further explored in in vitro cell lines and animal studies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。